Raed M. Zoubi-Al
Irbid, IR 22110, Jordan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 97 publications
ERβ-Score: An Interpretable Machine Learning-Based Scoring Function and Web Server for Estrogen Receptor β-Guided Drug Discovery in Triple-Negative Breast Cancer.
Journal: International journal of molecular sciences
Published: June 24, 2026
Urease inhibitors: current advances, therapeutic potentials, and clinical challenges.
Journal: Future medicinal chemistry
Published: June 15, 2026
Emerging antifungal agents in human medicine: Mechanisms, clinical progress, and future perspectives.
Journal: European journal of medicinal chemistry
Published: May 20, 2026
Combining Triazole Scaffold Repurposing and Generative Transformer Architecture for Structure-Based Inhibitor Design Targeting the LasR Quorum Sensing Receptor of Pseudomonas aeruginosa.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: April 14, 2026
Role of the Proteasome System in Shaping Cellular Immunological Characteristics and Its Impact in Modulating the Pathogenesis of Immune-Related Diseases.
Journal: Cells, tissues, organs
Published: April 09, 2026
Antiparasitic agents in oncology: Innovative mechanisms, emerging evidence and clinical potential in cancer treatment.
Journal: European journal of medicinal chemistry
Published: April 06, 2026
AKT2 Exon 3 Variants and Their Prevalence in Prostate Cancer Patients: Insights from a Jordanian Clinical Cohort.
Journal: International journal of molecular sciences
Published: April 03, 2026
An Integrative Computational Pipeline for CK2 Inhibitor Discovery in Triple-Negative Breast Cancer Using Virtual Screening, Molecular Dynamics, Machine Learning, and Density Functional Theory.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: March 17, 2026
Correction: Microsecond simulations to investigate the structural mechanism of super-resistant double mutations in BTK to the covalent inhibitor ibrutinib in multiple leukemia.
Journal: Scientific reports
Published: January 20, 2026
Inhibiting CK2 in breast cancer: From molecular targets to drug candidates.
Journal: European journal of medicinal chemistry
Published: December 07, 2025
Computational hybrid framework integrating clinical-mutation profiling and physics-based simulations to predict structural tolerance of Bruton tyrosine kinase (BTK) and sustained ARQ 531 binding.
Journal: Current research in structural biology
Published: October 12, 2025
Last Updated: 09/26/2026